The name of the base system (platform): | Artificial intelligence (AI, Artificial intelligence, AI) |
Developers: | MachineMD |
Date of the premiere of the system: | June 2023 |
Branches: | Pharmaceuticals, Medicine, Healthcare |
Main article: Human brain
2023: Neuroophthalmoscope for non-invasive brain assessment
The Swiss company MachineMD, which specializes in the production of medical equipment, has developed a neuro-ophthalmoscope designed to non-invasively assess the state of the brain and identify possible abnormalities.
Traditional ophthalmoscopes are limited in their ability to obtain detailed images of the retina and optic nerve, which are the most important indicators of various brain diseases. However, the MachineMD neuroophthalmoscope uses advanced technology visualization and (algorithms artificial intelligence AI) to produce detailed images of the eyes. This provides medical workers with the opportunity to get valuable information about the state of the brain, the information and analytical educational project reported on October 24, 2023. Evercare
In particular, the neuroophthalmoscope uses multispectral imaging technology, which allows you to obtain images at different wavelengths of light and identify hidden details that may go unnoticed using traditional methods. This advanced imaging technology, combined with AI algorithms trained on extensive data arrays, can detect subtle changes in the retina and optic nerve that may indicate the presence of brain diseases.
The device has an ergonomic design that provides ease of use and convenience for both healthcare professionals and patients. The simple interface and intuitive management make it accessible to a wide range of healthcare professionals, which ensures that it can be applied in a variety of healthcare settings.
At the same time, the effect of using the MachineMD neuroophthalmoscope goes beyond diagnosis. Thanks to the possibility of early detection and intervention, the device can save a life and significantly improve the quality of treatment of patients. Early detection of brain diseases can lead to timely treatment and management of patients, which will ultimately improve the quality of life of people suffering from these diseases.[1]